WNDM Medical Inc. Appoints Ron Nixon to the Board of Directors
March 22, 2019 at 02:08 am IST
Share
On March 15, 2019, Wound Management Technologies Inc., a Texas corporation doing business as WNDM Medical Inc. (WNDM), executed and closed an agreement with CGI Cellerate RX, LLC (CGI) of Houston, Texas, for WNDM to acquire the remaining 50% equity interest in Cellerate, LLC not then owned by WNDM. Following the closing of this transaction, Mr. Ron Nixon, Founder and Managing Partner of CGI, was elected to WNDM’s Board of Directors effective March 15, 2019. Mr. Nixon currently serves on the board of directors for publicly traded LHC Group Inc., Trilliant Surgical, LLC, Rochal Industries, LLC, Triad Life Sciences Inc. and several other privately held companies.
Sanara Medtech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It markets several products for surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products, CellerateRX Surgical, TEXAGEN, BiFORM, ACTIGEN, ALLOCYTE, ALLOCYTE Plus Advanced Viable Bone Matrix (ALLOCYTE Plus), BIASURGE, FORTIFY TRG Tissue Repair Graft (FORTIFY TRG), and FORTIFY FLOWABLE Extracellular Matrix (FORTIFY FLOWABLE) are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. CellerateRX Surgical products, TEXAGEN products, FORTIFY TRG and FORTIFY FLOWABLE are used in specialties, including cardiothoracic, colorectal, general surgery, hand, head and neck, high-risk obstetrics and gynecology, Mohs surgery, neurosurgery, and others.